CV Sciences Inc (CVSI)

[MartyTamreau]

DB: let's not get too far ahead of ourselves. CVSI has to actually do the clinical study with nicotine-CBD gum. They have to file the IND (investigational new drug), which I expect in the next 3 months. That alone is big news (press-release worthy)!! That has to happen before anything happens. After that happens, CVSI could start the clinical trial at their own risk (i.e., before waiting for feedback from FDA, which normally comes in 30 days). Then they start enrolling the study. The first patient in is also big news. This study should not take long to enroll. When the last patient is in, that's big news. The price will not lag until the study is completed, because this could all be happening in a relatively short period of time (and recall that CVSI has obtained accelerated approval). So once the IND is filed, this thing is going to get serious coverage. As I said earlier, there is no way that they will sell this thing off so early. Every time you move from phase 1 to phase II to phase III, the value goes up. News will be flying. They have huge assets in clinical development and consumer side. CVSI will become THE poster child for CBD. I hope that Mona and company hold this until the gum is approved, and then start the smoking cessation clinical development program. IMO. Just the beginning. I don't know the multiple, but it's not 1 or 2. All the best. MT